SABBY MANAGEMENT LLC
Q2 2024 Form 13-F

SPICEWOOD, TEXAS
CIK 0001535610 · CRD 162659 · Exempt reporting adviser
Consolidated report · includes 1 manager since Q3 2024
$148.7M Reported Value Total

SABBY MANAGEMENT, LLC reports 2 total accounts under management (AUM). There are 2 discretionary accounts valued at $223,496,960, and 0 non-discretionary accounts.

Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Exempt Reporting Adviser Discretionary Manager
Private funds (Form ADV)
2 funds · $197.4M gross asset value
Private Equity Fund: $181.5M · Hedge Fund: $15.8M
Source: Form ADV filed 2026-07-08
Reported value
$148.7M
Quarter over quarter
-29.8%
Holdings
27
Top-10 concentration
97.1%

Filing Structure

Reports holdings for

  • Hal Mintz (not a 13F filer in our records) · since Q3 2024 · declared by one filing
  • Mintz Hal · File #028-13502 · Q2 2013 – Q1 2025 · declared by one filing

Key People

Form ADV owners & control persons
Hal David Mintz
PRINCIPAL AND MANAGING MEMBER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC
Robert Alan Grundstein
CHIEF COMPLIANCE OFFICER OF SABBY MANAGEMENT, LLC AND SABBY CAPITAL, LLC

Filing Navigation

13F Metrics

Loading 13F Metrics

Q2 2024 13F record

Q2 2024 13F filing summary

Q2 2024 Form 13F portfolio summary
Period of report June 30, 2024
Filed August 14, 2024
Form 13F-HR
Reported value $148.7M
Positions 27
Change in reported value -14.2%
New positions 12
Exited positions 29
Position turnover 73.2%
Top-10 concentration 97.1%

13F filings by quarter

Form 13F filings by quarter
Quarter Positions Value
Q3 2026 13F
Filed Nov 13, 2026
14 $9.0M
Q2 2026 13F
Filed Aug 14, 2026
16 $110.5M
Q1 2026 13F
Filed May 15, 2026
22 $45.1M
Q4 2025 13F
Filed Feb 17, 2026
25 $69.5M
Q3 2025 13F
Filed Nov 14, 2025
29 $86.4M
Q2 2025 13F
Filed Aug 14, 2025
33 $55.1M
Q1 2025 13F
Filed May 15, 2025
36 $34.0M
Q4 2024 13F
Filed Feb 14, 2025
16 $76.9M
Q3 2024 13F
Filed Nov 14, 2024
27 $186.4M
Q2 2024 13F
Filed Aug 14, 2024
27 $148.7M
Q1 2024 13F
Filed May 15, 2024
43 $173.3M
Q4 2023 13F
Filed Feb 14, 2024
46 $100.0M
Q3 2023 13F
Filed Nov 14, 2023
66 $136.6M
Q2 2023 13F
Filed Aug 14, 2023
68 $122.2M
Q1 2023 13F
Filed May 15, 2023
72 $114.8M
Q4 2022 13F
Filed Feb 14, 2023
89 $114.0M
Q3 2022 13F
Filed Nov 14, 2022
82 $79.3M
Q2 2022 13F
Filed Aug 15, 2022
75 $147.0M
Q1 2022 13F
Filed May 16, 2022
83 $669.7M
Q4 2021 13F
Filed Feb 14, 2022
103 $687.8M

34 earlier quarters on file — choose one from the quarter menu above.

Top 20 holdings · Q2 2024

Largest Q2 2024 13F positions by reported value
# Holding Reported value % of portfolio
1 SPY P SPDR S&P 500 ETF TR $59.5M 40.04%
2 NYC P ISHARES TR $50.9M 34.26%
3 SPY C SPDR S&P 500 ETF TR $16.5M 11.13%
4 NYC C ISHARES TR $6.0M 4.01%
5 CORZ P CORE SCIENTIFIC $5.5M 3.69%
6 VANI VIVANI MEDICAL INC $2.7M 1.8%
7 BTBT P BIT DIGITAL INC $1.4M 0.92%
8 CORZW CORE SCIENTIFIC $762.1K 0.51%
9 CKPT P CHECKPOINT THERAPEUTICS INC $582.2K 0.39%
10 RDHL REDHILL BIOPHARMA LTD $497.2K 0.33%
11 CORZ C CORE SCIENTIFIC $459.4K 0.31%
12 GWAV GREENWAVE TECHNOLOGY $406.2K 0.27%
13 ELTK ELTEK LTD $395.5K 0.27%
14 IWM ISHARES TR $304.3K 0.2%
15 RVPH REVIVA PHARMACEUTCLS HLDGS INC $303.4K 0.2%
16 BIVI BIOVIE INC $293.6K 0.2%
17 LIPO LIPELLA PHARMACEUTICALS INC $243.1K 0.16%
18 SONN SONNET BIOTHERAPEUTICS HLDNG INC $223.5K 0.15%
19 SIDU SIDUS SPACE INC $194.5K 0.13%
20 ENSC ENSYSCE BIOSCIENCES INC $159.2K 0.11%

Values as reported on the Q2 2024 Form 13F. Every position is in the holdings table below.

Filing Details

Loading Activities
Loading Sector Allocation
Crunching numbers

Performance

Loading Performance

Potential New Buys

Finding Potential New Buys

Holdings

Building table
Loading SEC filing data
Loading Form 4 Filings

Beneficial Ownership (Schedule 13D/13G)

Loading 13D/G filings